The Keep Britain Working review update (A National Growth Opportunity, September 2026), led by Sir Charlie Mayfield and backed by the UK Government (DWP, DHSC, and DBT), shifts the national approach to workplace health from welfare based intervention to an economic growth driver. Keeping more people healthy and in work is one of Britain’s largest and most attainable growth opportunities. It is good for employers and employees, it strengthens the public finances, and it does n

Founders talk to each other constantly about raising money. They compare term sheets, trade notes on which VCs move fast, debate SAFE caps versus priced rounds, and celebrate the closes on LinkedIn with the requisite rocket emoji. What they don't talk about nearly as often, what almost never gets a celebratory post, is the much more common set of conversations that later-stage HealthTech founders actually have in board meetings in 2026: whether to take a down round, whether t

The closing of $5.75 billion across two dedicated artificial intelligence vehicles by Bessemer Venture Partners represents a watershed moment in the institutional capitalization of applied machine learning. Comprising a $1.75 billion pool committed to seed and early-stage rounds alongside a $4.0 billion growth fund, the raise provides the capital scale required to fund the AI stack from raw infrastructure to specialized vertical applications. Historically renowned for anchor

On September 21st, 2026, healthcare access intelligence and care orchestration platform DexCare, Inc. announced the acquisition of Mila Health, an emerging artificial intelligence care coordination company specialising in autonomous, multimodal conversational agents. The transaction marks DexCare’s second corporate acquisition following its October 2022 purchase of e-commerce storefront optimization platform Womp, Inc.. While financial terms were not publicly disclosed, the a

The convergence of diagnostic imaging, molecular biochemistry, and computational biology is altering the European digital health landscape. Zurich based preventive healthcare provider Aeon closed a strategic seed extension, expanding its cumulative seed financing past USD $14 million (surpassing €12 million) while simultaneously acquiring the core operational and technological assets of Berlin based blood diagnostics company Aware Health.

The National Health Service operates under structural strains characterised by emergency department congestion, acute bed occupancy frequently surpassing safe thresholds and persistent elective backlogs. The 2024 independent investigation into the NHS led by Lord Darzi concluded that the health service is in a "critical condition," citing an entrenched misallocation of financial, capital, and operational resources. In England, expenditure remains heavily skewed toward acute

The convergence of chronic clinical workforce deficits, escalating administrative burdens, and generative artificial intelligence has elevated ambient voice technology (AVT) from experimental workflow assistance into critical healthcare infrastructure. The capitalisation of Stockholm-based Tandem Health, securing a $100 million Series B led by the European Commission-backed Scaleup Europe Fund managed by EQT—closely followed by Australia based Heidi Health closing a $340 mill

The international prominence of Scandinavian healthtech enterprises, highlighted by Oura Health’s multi-billion-dollar valuation and public filing, Neko Health’s rapid deployment of preventive diagnostic clinics, and Tandem Health’s enterprise rollout of ambient clinical artificial intelligence, is frequently interpreted as a sudden regional phenomenon. In reality, the emergence of Sweden, Finland and Denmark as major exporters of biomedical hardware, consumer health platform

During the initial growth cycle of consumer wearable technology, venture capital allocations and equity valuations were tethered directly to consumer electronics benchmarks: industrial design, miniaturization of components, unit shipment volume, and hardware gross margins. The contemporary investment thesis has decisively broken with this framework. Institutional capital, private equity sponsors, and Big Tech acquirers now regard consumer hardware as a low-margin, commoditise

Nelson Advisors: Specialists in European HealthTech, MedTech, Healthcare AI and Digital Health. Partnerships, Investments, Mergers & Acquisitions from $25M to $250M Enterprise Value. The European healthcare technology M&A landscape is undergoing a structural realignment, and it is happening quietly. There is no single headline moment to point to, no dramatic collapse or blockbuster deal that marks the shift. Instead, the change has been cumulative: a gradual hollowing out of

Julien Bek’s thesis, "Services: The New Software," argues that the next generation of decacorn and trillion dollar technology companies will not sell software tools to knowledge workers; instead, they will sell the completed work product directly, operating as software companies masquerading as services firms. Across the broader macroeconomic landscape, enterprises allocate approximately six dollars to human professional services for every single dollar spent on software. In

How a London communications platform and a Stockholm AI company built the NHS's fastest scaling ambient scribe, and what founders and investors should take from it. Strategic partnerships in HealthTech are announced often and delivered rarely. The press release is easy; the shared roadmap, the aligned commercial incentives and the willingness to let another company sit between you and your customer are hard. Which is why Accurx Scribe, powered by Tandem, deserves attention as

Fewer, larger, more selective: what the first half of 2026 tells us about where private capital is going in MedTech, and how investors should think about carve-outs, take-privates and the categories that are attracting the biggest cheques. The headline number for MedTech M&A in 2026 is striking. In the first half of the year, deal value was roughly 160% higher than the same period in 2025. The more interesting number sits beside it: deal count rose by just 5%. Average deal v

European HealthTech continues to see heavy capital flow toward clinical workflow automation, platform consolidation and regulatory alignment under evolving EU frameworks. Tandem Health (Sweden) raised $100M in Series B funding, backed by the EU's €5B tech startup initiative, to scale its clinical workflow and administrative AI platform across European healthcare networks. Venture capital continues shifting decisively away from standalone consumer wellness apps, heavily pr

Nine months ago, Angle Health closed what looked like a strong Series B. The San Francisco health benefits company raised $134 million in a mix of debt and equity led by Portage, bringing its total funding to just under $200 million. It was a respectable round for a company that most people outside the US employer benefits market had never heard of. Now, according to the Wall Street Journal, European mid market private equity firm Vitruvian Partners is leading a $600 Million